Activation of the insulin-like growth factor type 1 receptor by deletion of amino acids 870-905

被引:4
作者
Li, S [1 ]
Zhang, H [1 ]
Hoff, H [1 ]
Sell, C [1 ]
机构
[1] Allegheny Univ, MCP Hahnemann Sch Med, Dept Pathol & Lab Med, Gerontol Res Ctr, Philadelphia, PA 19129 USA
关键词
insulin-like growth factor 1; tyrosine kinase; cell proliferation; transformation;
D O I
10.1006/excr.1998.4167
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have created a deletion mutant of the insulinlike growth factor type 1 receptor (IGF-1 R) which lacks the 36 amino acids (aa) immediately N-terminal to the transmembrane domain (Delta 870-905 IGF-1 R), This region has been reported to have a negative effect on the transforming potential of an avian sarcoma virus gag-IGF-l R fusion protein, We have sought to determine whether this region plays a similar role in the intact IGF-1 R. Analysis of the tyrosine kinase activity of the Delta 870-905 IGF-1 R shows that the mutant receptor is autophosphorylated without IGF-1 stimulation, indicating that the tyrosine kinase domain is constitutively active, In addition, processing of the receptor is decreased, resulting in accumulation of a high molecular weight proreceptor containing both a and beta-subunits. A well-characterized substrate of the IGF-1 R, IRS-1, is constitutively phosphorylated by the Delta 870-905 IGF-1 R and phosphoinositide (PI) 3-kinase activity, which is normally activated by the phosphorylation of IRS-1 following IGF-1 stimulation, is increased even in the absence of IGF-1. A second intracellular signal pathway normally activated by IGF-I, the MAP kinase pathway, showed no increase in activity in the absence of IGF-1. The Delta 870-905 IGF-1 R promoted cell proliferation only in the presence of IGF-1. We conclude that this deletion increases the basal activity of the IGF-1 receptor tyrosine kinase and activates PI 3-kinase, but is unable to stimulate MAP kinase in the absence of ligand, These results confirm those seen in the gag-IGF-l R fusion protein and indicate that aa 870-905 exert a negative effect on the tyrosine kinase domain of the beta-subunit of the IGF-1 R. (C) 1998 Academic Press.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 50 条
  • [21] The dichotomy of the Insulin-like growth factor 1 receptor: RTK and GPCR: friend or foe for cancer treatment?
    Crudden, Caitrin
    Ilic, Marina
    Suleyrnanova, Naida
    Worrall, Claire
    Girnita, Ada
    Girnita, Leonard
    GROWTH HORMONE & IGF RESEARCH, 2015, 25 (01) : 2 - 12
  • [22] The possible role of insulin-like growth factor-1 in osteosarcoma
    Li, Yu-sheng
    Liu, Qing
    He, Hong-bo
    Luo, Wei
    CURRENT PROBLEMS IN CANCER, 2019, 43 (03) : 228 - 235
  • [23] Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer
    Singh, Pushpendra
    Alex, Jimi Marin
    Bast, Felix
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [24] Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
    Buck, Elizabeth
    Gokhale, Prafulla C.
    Koujak, Susan
    Brown, Eric
    Eyzaguirre, Alexandra
    Tao, Nianjun
    Rosenfeld-Franklin, Maryland
    Lerner, Lorena
    Chiu, M. Isabel
    Wild, Robert
    Epstein, David
    Pachter, Jonathan A.
    Miglarese, Mark R.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (10) : 2652 - 2664
  • [25] All-Atom Structural Models of the Transmembrane Domains of Insulin and Type 1 Insulin-Like Growth Factor Receptors
    Mohammadiarani, Hossein
    Vashisth, Harish
    FRONTIERS IN ENDOCRINOLOGY, 2016, 7
  • [26] Daintain/AIF-1 accelerates the activation of insulin-like growth factor-1 receptor signaling pathway in HepG2 cells
    Jia, Shaohui
    Du, Zhongxia
    Jiang, Hua
    Huang, Xingyuan
    Chen, Zhengwang
    Chen, Ning
    ONCOLOGY REPORTS, 2015, 34 (01) : 511 - 517
  • [27] Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy
    Tognon, Cristina E.
    Sorensen, Poul H. B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (01) : 33 - 48
  • [28] Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor
    Hongo, A
    DAmbrosio, C
    Miura, M
    Morrione, A
    Baserga, R
    ONCOGENE, 1996, 12 (06) : 1231 - 1238
  • [29] Effects of SNP within Exon 7 of the Insulin-like Growth Factor Receptor Type 1 (IGF1R) Gene on Growth Traits in Angus Cows
    Szewczuk, Malgorzata
    JOURNAL OF AGRICULTURAL SCIENCES-TARIM BILIMLERI DERGISI, 2016, 22 (04): : 492 - 499
  • [30] Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy
    Wu, Jennifer
    Yu, Evan
    CANCER AND METASTASIS REVIEWS, 2014, 33 (2-3) : 607 - 617